Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Clinical Medicine (Fall 2016) > P6: Parkinson's Disease > Flashcards

P6: Parkinson's Disease Flashcards

(63 cards)

Start Studying
1
Q

what type of disease is Parkinson Disease

A

neurodegenerative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what % of the population over 60 has Parkinson Disease

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the classic symptoms of Parkinson Disease (4)

A
  1. rigidity
  2. resting tremor of hands
  3. bradykinesia
  4. postural instability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is bradykinesia

A

slow movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the primary cause of Parkinson Disease and what part of the brain is affected

A

degeneration of dopaminergic neurons in substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

in the basal ganglia, what two neurotransmitters are in balance with one another

A

dopamine and acetlycholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what happens in Parkinson’s when dopamine is decreased (directly)

A

Ach increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what other NTs are affected by the depletion of dopamine (4)

A
  1. GABA
  2. glutamate
  3. 5-HT (serotonin)
  4. norepinephrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the process of creation of dopamine (3 step process)

A
  1. tyrosine

–>

  1. dopa

–>

  1. dopamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what enzyme transforms tyrosine into dopa

A

tyrosine hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what enzyme transforms dopa into dopamine

A

dopa decarboxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

will dopa cross the blood brain barrier

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

will dopamine cross the blood brain barrier

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what part of dopa can cross the BBB

A

L-hand isomer (levodopa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the rationale for levopoa therapy (3)

A
  1. attempt to increase dopamine content in the basal ganglia
  2. direct administration of dopamine ineffective because dopamine can’t cross the BBB
  3. must provide precursor to dopamine (levodopa (L-DOPA))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does the BBB divide

A

cerebral capillary and cerebral tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the role of the BBB

A

be selective on what can and can’t reach the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

once L-DOPA crosses the BBB, what enzyme converts it to dopamine

A

DOPA decarboxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the problem with DOPA decarboxylase

A

it’s found in the blood stream and brain.. L-DOPA needs to be converted to dopamine in the brain, not the blood.. means we need another drug to protect it until it can reach the brain (carbidopa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what drug is a protective drug that is often given with L-DOPA

A

carbidopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

brain or blood stream:

90% of L-DOPA is converted to dopamine here

A

the blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

mechanism of carbidopa

A

inhibits dopa decarboxylase (prevents premature conversion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what two things are often included in the same pill

A

l-dopa and carbidopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

side effects of L-Dopa therapy (5)

A
  1. GI irritation
  2. hypotension
  3. psychotropic, behavioral effects
  4. dyskinesias
  5. “freezing” of gait
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
in l-dopa therapy, there are fluctuations in response to l-dopa.. what are the two types
1. end-of-dose akinesia | 2. on-off phenomenon
26
what is the end-of-dose akinesia
decreased response toward end of cycle
27
what is the on-off phenomenon
response fluctuates within dose cycle
28
for l-dopa therapy, what type of response may be present with long-term use
diminished response
29
benefits may be lost after ____-____ of l-dopa therapy
4-5 years
30
what are the two ideas for why a diminished response is present for l-dopa therapy
1. tolerance builds | 2. disease is progressing and getting worse, the drug can't be supplied enough to give them what they need
31
if a tolerance to the drug is present, what should we do
delay the administration
32
if the disease is too progressed that the drugs won't help, what should we do
use as needed (when symptoms are the worst)
33
do dopamine agonists cross the BBB
yes
34
what do dopamine agonists do after they cross the BBB
stimulate dopamine receptors
35
what is noted regarding half-life for dopamine agonists
longer half-life
36
what does the longer half-life do for dopamine agonists
cause more stable responses
37
what can dopamine agonists be used for
initial treatment in early Parkinson Disease
38
dopamine agonists may be ____
neuroprotective
39
what stage of parkinson disease are dopamine agonists generally used in
early
40
problems with dopamine agonists (4)
1. nausea/vomiting 2. confusion, hallucinations 3. postural hypotension 4. increased dyskinesia
41
what are the problems with dopamine agonists similar to
parkinson disease
42
what does catechol-O-methyltransferase (COMT) do
enzyme that breaks down l-dopa in peripheral tissue
43
what do COMT inhibitors do
allow more l-dopa to reach the brain
44
benefits of COMT inhibitors (2)
1. decrease fluctuations | 2. increase "on-time" in on-off phenomenon
45
what does COMT break l-dopa into
3-O-methyldopa (useless)
46
what can be combined with L-DOPA and carbidopa
COMT inhibitors
47
what are are problems with COMT inhibitors (3)
1. GI distress (diarrhea) 2. orthostatic hypotension 3. increased dyskinesia
48
what do anticholinergic drugs do
decrease acetlycholine
49
what does anticholinergic drugs decreasing acetlycholine do
help decrease rigidity and tremor
50
anticholinergic agents are limited somewhat by side effects known as
anticholinergic package
51
mechanism of MAO-B inhibitors
inhibit monamine oxidase type B (MAO-B)
52
what do MAO-B inhibitors do
prolong dopamine effects in brain
53
what do MAO-B inhibitors combine with to increase and prolong effects
l-dopa
54
what are the major problems with MAO-B
no major concerns
55
MAO-B inhibitors have possible ____ effects
neuroprotective
56
amantadine was initially created to treat...
the flu
57
amantadine is a ____ agent
antiviral
58
mechanism of amantadine
blocks NMDA receptor in brain
59
by blocking the NMDA receptor in the brain, what does amantadine do
decreases influence of excitatory amino acids (glutamate)
60
amantadine decreases chance of
dyskinesias
61
problems with amantadine (3)
1. orthostatic hypotension 2. psychotropic effect 3. skin discoloration
62
when is the optimal treatment time for antiparkinson drugs
30 to 60 minutes after meds
63
what are three future considerations of parkinson disease
1. tissue transplant 2. surgery 3. role of toxins

Clinical Medicine (Fall 2016) (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions